# PGL5001 Proof of Concept Study in Inflammatory Endometriosis

> **NCT01630252** · PHASE2 · COMPLETED · sponsor: **PregLem SA** · enrollment: 24 (actual)

## Conditions studied

- Endometriosis

## Interventions

- **DRUG:** PGL5001
- **DRUG:** Placebo
- **DRUG:** PGL5001
- **DRUG:** Placebo
- **DRUG:** PGL5001

## Key facts

- **NCT ID:** NCT01630252
- **Lead sponsor:** PregLem SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2013-09
- **Final completion:** 2013-10
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2014-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01630252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01630252, "PGL5001 Proof of Concept Study in Inflammatory Endometriosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01630252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*